Clinical Trials in Miami

Showing 2621-2640 of 5,521 trials

Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency

NCT03815396

This is an open-label, 2-part, dose-escalating, Phase 1 study of INBRX-101 (rhAAT-Fc). Part 1 will consist of single ascending dose (SAD) administration of INBRX-101 and Part 2 will consist of multiple ascending dose (MAD) administrations of INBRX-101. The planned dosing schedule is IV every 3 to 4 weeks.

Alpha-1 Antitrypsin DeficiencyAATD

Inhibrx Biosciences, Inc31 participantsStarted Jul 2019

Sacramento, California, United States • Gainesville, Florida, United States • Miami, Florida, United States +7 more locations

COMPLETEDNA< 1 mile

Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19

NCT04662671

This randomized, Phase I/II feasibility study will evaluate the safety and efficacy of the RD-X19 device in SARS-CoV-2 infected individuals with uncomplicated COVID-19.

COVID19

EmitBio Inc.31 participantsStarted Nov 2020

Miami, Florida, United States • College Station, Texas, United States

UNKNOWNPhase 2< 1 mile

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

NCT04880187

This study will compare the effects of AXA1125, an orally active mixture of amino acids, compared to placebo, on improving fat and inflammation (steatohepatitis) as well as fibrosis in subjects with non alcoholic steatohepatitis (NASH). as well as the safety and tolerability of AXA1125. Subjects will take one of two different doses of AXA1125 or a placebo twice daily, and a liver biopsy will be done at the beginning and end of the 48-week study.

Non Alcoholic Steatohepatitis (NASH)

Axcella Health, Inc273 participantsStarted May 2021

Cullman, Alabama, United States • Tucson, Arizona, United States • Tucson, Arizona, United States +72 more locations

Phase 1 Study to Assess the Safety, PK and PD of INBRX-101 in Adults With Alpha-1 Antitrypsin Deficiency

Phase I/II Safety, Dose Finding & Antiviral Activity of RD-X19 in Mild/Moderate Outpatient COVID-19

Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

Find Trials by Condition in Miami

Antithrombin III in Infectious Disease Caused by COVID-19

The Safety, Efficacy and Pharmacokinetics of ARQ-151 Cream in Subjects With Chronic Plaque Psoriasis

A Prospective Study of Early Mechanical Stabilization and Bleeding in Disruption of the Pelvic Ring

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

Stress-induced Scratching in Healthy and AD

A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients

Efficacy and Safety of a New Dilution and Injection Volume of AbobotulinumtoxinA for the Treatment of Glabellar Lines

Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

A Study to Evaluate Seladelpar in Subjects With Nonalcoholic Steatohepatitis (NASH)

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Study to Assess the Effectiveness of AboBoNT-A Injections for Adult Lower Limb Spasticity in a Real Life Cohort

Phase I/II Study of PDR001 in Patients With Advanced Malignancies

A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation